Stifel Financial Corp Takeda Pharmaceutical CO LTD Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Stifel Financial Corp holds 216,072 shares of TAK stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

216,072

Previous 294,215 26.56%

Holding current value

$2.99 Million

Previous $4.09 Million 31.6%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.6 - $13.67 $984,601 - $1.07 Million	-78,143 Reduced 26.56%	216,072 $2.8 Million
Q1 2024 May 13, 2024	BUY	$13.89 - $15.04 $1.19 Million - $1.29 Million	85,772 Added 41.15%	294,215 $4.09 Million
Q4 2023 Feb 12, 2024	SELL	$13.36 - $15.43 $1.14 Million - $1.32 Million	-85,370 Reduced 29.06%	208,443 $2.97 Million
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $221,932 - $240,981	14,766 Added 5.29%	293,813 $4.55 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $60,084 - $66,027	3,859 Added 1.4%	279,047 $4.38 Million
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $2.47 Million - $2.67 Million	161,919 Added 142.95%	275,188 $4.54 Million
Q4 2022 Feb 13, 2023	SELL	$12.42 - $15.62 $129,515 - $162,885	-10,428 Reduced 8.43%	113,269 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $194,329 - $434,964	15,182 Added 13.99%	123,697 $1.6 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $166,348 - $190,565	12,679 Added 13.23%	108,515 $1.52 Million
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $120,289 - $136,369	8,884 Added 10.22%	95,836 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $134,492 - $167,476	10,212 Added 13.31%	86,952 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $198,501 - $210,192	12,178 Added 18.86%	76,740 $1.26 Million
Q2 2021 Aug 13, 2021	BUY	$16.55 - $18.64 $6,338 - $7,139	383 Added 0.6%	64,562 $1.09 Million
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $1.56 Million - $1.85 Million	-93,125 Reduced 59.2%	64,179 $1.17 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $664,617 - $819,219	-43,185 Reduced 21.54%	157,304 $2.86 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $70,400 - $79,005	-4,117 Reduced 2.01%	200,489 $3.58 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $205,120 - $274,150	-14,059 Reduced 6.43%	204,606 $3.67 Million
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $37,120 - $57,903	2,851 Added 1.32%	218,665 $3.32 Million
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $432,955 - $534,268	25,649 Added 13.49%	215,814 $4.26 Million
Q3 2019 Nov 19, 2019	BUY	$16.15 - $17.99 $2,390 - $2,662	148 Added 0.08%	190,165 $3.27 Million
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $291,329 - $324,521	-18,039 Reduced 8.67%	190,017 $3.27 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $108,400 - $133,963	6,538 Added 3.24%	208,056 $3.68 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $3.37 Million - $4.34 Million	201,518 New	201,518 $4.1 Million

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Takeda Pharmaceutical CO LTD Transaction History